These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12975722)

  • 61. Evolution of self-care with over-the-counter medications.
    Soller RW
    Clin Ther; 1998; 20 Suppl C():C134-40. PubMed ID: 9915100
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The risks and benefits of an Rx-to-OTC switch. The case of over-the-counter H2-blockers.
    Oster G; Huse DM; Delea TE; Colditz GA; Richter JM
    Med Care; 1990 Sep; 28(9):834-52. PubMed ID: 1976142
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Human resources for the approval of new drugs in Canada, Australia, Sweden, the United Kingdom and the United States.
    Rawson NS
    Can J Clin Pharmacol; 2002; 9(2):73-8. PubMed ID: 12172587
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cost effectiveness of omeprazole and ranitidine in intermittent treatment of symptomatic gastro-oesophageal reflux disease.
    Stålhammar NO; Carlsson J; Peacock R; Müller-Lissner S; Bigard MA; Porro GB; Ponce J; Hosie J; Scott M; Weir DG; Fulton C; Gillon K; Bardhan KD
    Pharmacoeconomics; 1999 Nov; 16(5 Pt 1):483-97. PubMed ID: 10662395
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Cost comparative analysis of drug therapy for non-steroidal anti-inflammatory drug (NSAID)-induced gastric ulcer in Japan].
    Hashiguchi M; Yamauchi N; Uchikura T; Mochizuki M
    Yakugaku Zasshi; 2008 Apr; 128(4):585-94. PubMed ID: 18379175
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The FDA and drug safety: a proposal for sweeping changes.
    Furberg CD; Levin AA; Gross PA; Shapiro RS; Strom BL
    Arch Intern Med; 2006 Oct; 166(18):1938-42. PubMed ID: 17030825
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Resigning over Plan B OTC: an interview with Susan F. Wood by Diana Mason.
    Wood SF
    Am J Nurs; 2007 Mar; 107(3):56-7. PubMed ID: 17314559
    [No Abstract]   [Full Text] [Related]  

  • 68. Heal the damage: prescription drug consumer advertisements and relative choices.
    Gilhooley M
    J Health Law; 2005; 38(1):1-44. PubMed ID: 15968938
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cost of acid peptic disorders in a managed-care organization.
    Segal R; Russell WL; Ben-Joseph R; Mansheim B
    Clin Ther; 1996; 18(2):319-33; discussion 302. PubMed ID: 8733992
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evaluation of omeprazole as a cost-effective diagnostic test for gastro-oesophageal reflux disease.
    Bate CM; Riley SA; Chapman RW; Durnin AT; Taylor MD
    Aliment Pharmacol Ther; 1999 Jan; 13(1):59-66. PubMed ID: 9892880
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Omeprazole isomer approved by FDA.
    Thompson CA
    Am J Health Syst Pharm; 2001 Apr; 58(8):645. PubMed ID: 11329754
    [No Abstract]   [Full Text] [Related]  

  • 72. Extent and variation of omeprazole prescribing in an elderly population of Ontario.
    McBride JE; Pater JL; Dorland JL; Lam YM
    Ann Pharmacother; 1997 Apr; 31(4):411-6. PubMed ID: 9101000
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Changing the status of drugs from prescription to over-the-counter availability.
    Brass EP
    N Engl J Med; 2001 Sep; 345(11):810-6. PubMed ID: 11556302
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pharmacy compounding primer for physicians: prescriber beware.
    Sellers S; Utian WH
    Drugs; 2012 Nov; 72(16):2043-50. PubMed ID: 23039281
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Did FDA Decisionmaking Affect Anti-Psychotic Drug Prescribing in Children?: A Time-Trend Analysis.
    Wang B; Franklin JM; Eddings W; Landon J; Kesselheim AS
    PLoS One; 2016; 11(3):e0152195. PubMed ID: 27032095
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Switching from prescription to over-the counter medications: a consumer and managed care perspective.
    Pawaskar MD; Balkrishnan R
    Manag Care Interface; 2007 Jan; 20(1):42-7. PubMed ID: 17310652
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Should you let the FDA decide what drugs you pay for?
    Dutton G
    Bus Health; 1996 Oct; 14(10):65, 69-70, 73. PubMed ID: 10161492
    [No Abstract]   [Full Text] [Related]  

  • 78. Labeling for bronchodilators to treat asthma; cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2011 Jul; 76(143):44475-89. PubMed ID: 21796845
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Status of certain additional over-the-counter drug category II and III active ingredients. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 May; 67(90):31123-5. PubMed ID: 12001971
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Decision analysis of Helicobacter pylori eradication therapy using omeprazole with either clarithromycin or amoxicillin.
    Craig AM; Davey P; Malek M; Murray F
    Pharmacoeconomics; 1996 Jul; 10(1):79-92. PubMed ID: 10160472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.